IL227890A0 - Antiaging compounds containing bile acid and fatty acid conjugates - Google Patents

Antiaging compounds containing bile acid and fatty acid conjugates

Info

Publication number
IL227890A0
IL227890A0 IL227890A IL22789013A IL227890A0 IL 227890 A0 IL227890 A0 IL 227890A0 IL 227890 A IL227890 A IL 227890A IL 22789013 A IL22789013 A IL 22789013A IL 227890 A0 IL227890 A0 IL 227890A0
Authority
IL
Israel
Prior art keywords
fatty acid
aging compositions
conjugates
bile acid
bile
Prior art date
Application number
IL227890A
Other languages
English (en)
Hebrew (he)
Original Assignee
Galderm Therapeutics Ltd
Nava Dayan
Allen Baharaff
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderm Therapeutics Ltd, Nava Dayan, Allen Baharaff filed Critical Galderm Therapeutics Ltd
Priority to IL227890A priority Critical patent/IL227890A0/en
Publication of IL227890A0 publication Critical patent/IL227890A0/en
Priority to JP2016532791A priority patent/JP2016527306A/ja
Priority to US14/910,477 priority patent/US20160175223A1/en
Priority to CA2920456A priority patent/CA2920456A1/en
Priority to CN201480055618.6A priority patent/CN105611910A/zh
Priority to EP14834924.4A priority patent/EP3030221A4/en
Priority to PCT/IL2014/050717 priority patent/WO2015019358A1/en
Priority to HK16112516.2A priority patent/HK1224198A1/zh
Priority to AU2014304078A priority patent/AU2014304078A1/en
Priority to IL243964A priority patent/IL243964A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL227890A 2013-08-08 2013-08-08 Antiaging compounds containing bile acid and fatty acid conjugates IL227890A0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IL227890A IL227890A0 (en) 2013-08-08 2013-08-08 Antiaging compounds containing bile acid and fatty acid conjugates
JP2016532791A JP2016527306A (ja) 2013-08-08 2014-08-07 胆汁酸−脂肪酸抱合体を含む抗老化組成物
US14/910,477 US20160175223A1 (en) 2013-08-08 2014-08-07 Anti-aging compositions comprising bile acid-fatty acid conjugates
CA2920456A CA2920456A1 (en) 2013-08-08 2014-08-07 Anti-aging compositions comprising bile acid-fatty acid conjugates
CN201480055618.6A CN105611910A (zh) 2013-08-08 2014-08-07 包含胆汁酸-脂肪酸缀合物的抗老化组合物
EP14834924.4A EP3030221A4 (en) 2013-08-08 2014-08-07 Anti-aging compositions comprising bile acid-fatty acid conjugates
PCT/IL2014/050717 WO2015019358A1 (en) 2013-08-08 2014-08-07 Anti-aging compositions comprising bile acid-fatty acid conjugates
HK16112516.2A HK1224198A1 (zh) 2013-08-08 2014-08-07 包含胆汁酸- 脂肪酸缀合物的抗老化组合物
AU2014304078A AU2014304078A1 (en) 2013-08-08 2014-08-07 Anti-aging compositions comprising bile acid-fatty acid conjugates
IL243964A IL243964A0 (en) 2013-08-08 2016-02-04 Antiaging preparations containing bile acid and fatty acid conjugates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL227890A IL227890A0 (en) 2013-08-08 2013-08-08 Antiaging compounds containing bile acid and fatty acid conjugates

Publications (1)

Publication Number Publication Date
IL227890A0 true IL227890A0 (en) 2014-01-30

Family

ID=50022996

Family Applications (2)

Application Number Title Priority Date Filing Date
IL227890A IL227890A0 (en) 2013-08-08 2013-08-08 Antiaging compounds containing bile acid and fatty acid conjugates
IL243964A IL243964A0 (en) 2013-08-08 2016-02-04 Antiaging preparations containing bile acid and fatty acid conjugates

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL243964A IL243964A0 (en) 2013-08-08 2016-02-04 Antiaging preparations containing bile acid and fatty acid conjugates

Country Status (9)

Country Link
US (1) US20160175223A1 (cg-RX-API-DMAC7.html)
EP (1) EP3030221A4 (cg-RX-API-DMAC7.html)
JP (1) JP2016527306A (cg-RX-API-DMAC7.html)
CN (1) CN105611910A (cg-RX-API-DMAC7.html)
AU (1) AU2014304078A1 (cg-RX-API-DMAC7.html)
CA (1) CA2920456A1 (cg-RX-API-DMAC7.html)
HK (1) HK1224198A1 (cg-RX-API-DMAC7.html)
IL (2) IL227890A0 (cg-RX-API-DMAC7.html)
WO (1) WO2015019358A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160175324A1 (en) * 2013-08-08 2016-06-23 Galderm Therapeutics Ltd. Anti-acne compositions comprising bile acid-fatty acid conjugates
US11571431B2 (en) 2013-12-04 2023-02-07 Galmed Research And Development Ltd Aramchol salts
WO2016199137A1 (en) 2015-06-10 2016-12-15 Galmed Research And Development Ltd. Low dose compositions of aramchol salts
US20180000793A1 (en) 2015-02-06 2018-01-04 Ernesto Abel-Santos Inhibiting Germination of Clostridium Perfringens Spores to Reduce Necrotic Enteritis
IL243707A0 (en) 2016-01-20 2016-05-01 Galmed Res And Dev Ltd Treatment to regulate the microbiota in the intestine
US11197870B2 (en) 2016-11-10 2021-12-14 Galmed Research And Development Ltd Treatment for hepatic fibrosis
CN109503693B (zh) * 2018-12-12 2021-04-06 合肥工业大学 一种利用胆酸为原料合成Aramchol的工艺
JP2021100925A (ja) * 2019-10-31 2021-07-08 共栄化学工業株式会社 皮膚外用剤
WO2023287261A1 (ko) * 2021-07-16 2023-01-19 주식회사 스카이테라퓨틱스 담즙산 또는 담즙산 염의 분자 회합체를 포함하는 화장료 조성물
WO2023039159A2 (en) * 2021-09-09 2023-03-16 Abel Santos Ernesto Inhibitors of c. difficile spore germination
WO2024012317A1 (zh) * 2022-07-14 2024-01-18 爱医谷(苏州)生物科技有限公司 一种用于抵抗衰老的组合物及其用途或方法
CN116236490A (zh) * 2023-02-14 2023-06-09 四川大学 脱氧胆酸的用途及药物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115313A (en) * 1974-10-08 1978-09-19 Irving Lyon Bile acid emulsions
IL142650A (en) * 1998-04-08 2007-06-03 Galmed Int Ltd Use of bile acid conjugates or bile salts and fatty acids or fatty acids in the preparation of pharmaceuticals for lowering cholesterol, for the treatment of fatty liver and for the treatment of hyperglycemia and diabetes
US6019992A (en) * 1998-12-04 2000-02-01 Chesebrough-Pond's Usa Co. Cosmetic skin care compositions containing 4-chromanone
US8975246B2 (en) * 2001-04-17 2015-03-10 Galmed Research And Development Ltd. Bile acid or bile salt fatty acid conjugates
US20060127468A1 (en) * 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
ES2296463B1 (es) * 2005-07-13 2009-02-16 Universidade De Santiago Compostela Nuevos amidoderivados de acidos billares funcionalizados en la posicion 3 del anillo a. procedimientos para su obtencion y aplicaciones.
GB0722077D0 (en) * 2007-11-09 2007-12-19 Smithkline Beecham Corp Compounds
JP5872158B2 (ja) * 2008-03-11 2016-03-01 株式会社 資生堂 皮膚美白方法、並びに、皮膚シミ形成抑制及び／又は除去因子のスクリーニング方法
US8937194B2 (en) * 2008-12-31 2015-01-20 Nitromega Corp. Topical compositions containing nitro fatty acids
WO2010086864A1 (en) * 2009-02-02 2010-08-05 Galmed International Ltd. Methods and compositions for treating alzheimer's disease
US20160175324A1 (en) * 2013-08-08 2016-06-23 Galderm Therapeutics Ltd. Anti-acne compositions comprising bile acid-fatty acid conjugates
LT3077047T (lt) * 2013-12-04 2019-08-26 Galmed Research & Development Ltd. Aramcholio druskos

Also Published As

Publication number Publication date
US20160175223A1 (en) 2016-06-23
CA2920456A1 (en) 2015-02-12
WO2015019358A1 (en) 2015-02-12
JP2016527306A (ja) 2016-09-08
CN105611910A (zh) 2016-05-25
AU2014304078A1 (en) 2016-02-25
EP3030221A4 (en) 2017-02-08
HK1224198A1 (zh) 2017-08-18
IL243964A0 (en) 2016-04-21
EP3030221A1 (en) 2016-06-15

Similar Documents

Publication Publication Date Title
IL274971A (en) Compositions of silver nanoparticle coating and methods
IL273205A (en) Preparations and methods
IL227890A0 (en) Antiaging compounds containing bile acid and fatty acid conjugates
GB2533892B (en) Compositions and methods
ZA201408594B (en) Xylitol-based anti-mucosal compositions and related methods and compositions
GB201308072D0 (en) Compositions and methods
SI2860211T1 (sl) Sestavki estra fosforne kisline z zmanjšano higroskopičnostjo
GB2511350B (en) Skincare compositions
ZA201504274B (en) Compositions comprising vortioxetine and donepezil
IL276126B (en) Preparations containing l-4-chloroquinonerine and their uses
GB201305813D0 (en) Compositions and methods
IL218364A0 (en) Responsivity enhancement for thermochromic compositions and devices
IL245601A0 (en) Niacin fatty acid conjugates
EP2964610A4 (en) VINYL SULFON-BASED 18F LABELING COMPOSITIONS AND METHOD AND USES THEREOF
GB201315350D0 (en) Methods and compositions
GB201305556D0 (en) Skincare compositions
GB201315347D0 (en) Methods and compositions
EP2874641A4 (en) COMPOSITIONS INCREASING THE GLUTATHION RATE AND USES THEREOF
IL235154A0 (en) Preparations containing substances to reduce uric acid and anti-inflammatory substances and their uses
ZA201604587B (en) Testosterone gel compositions and related methods
SG11201501534QA (en) Fluorescence-labelled fatty acids and uses thereof
SG11201502069SA (en) Beta-hydroxy-beta-methylbutryic acid- containing compositions and uses thereof
IL243965A0 (en) Anti-acne preparations containing bile acid and fatty acid conjugates
IL246134A0 (en) Gel preparations containing testosterone and their uses
GB201317267D0 (en) Chitin-chitosan hydrocel compositions and their uses